RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 71 filers reported holding RECRO PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $130,000 | +271.4% | 46,770 | +278.4% | 0.00% | – |
Q4 2020 | $35,000 | -32.7% | 12,359 | -49.8% | 0.00% | – |
Q3 2020 | $52,000 | -53.6% | 24,627 | 0.0% | 0.00% | – |
Q2 2020 | $112,000 | -46.7% | 24,627 | +114.5% | 0.00% | – |
Q4 2019 | $210,000 | +32.9% | 11,481 | -19.4% | 0.00% | – |
Q3 2019 | $158,000 | -72.9% | 14,251 | -75.1% | 0.00% | – |
Q2 2019 | $582,000 | +9.0% | 57,179 | -37.3% | 0.00% | – |
Q1 2019 | $534,000 | -32.2% | 91,191 | -17.9% | 0.00% | – |
Q4 2018 | $788,000 | -1.4% | 111,047 | -1.2% | 0.00% | – |
Q3 2018 | $799,000 | +33.4% | 112,447 | -5.8% | 0.00% | – |
Q2 2018 | $599,000 | -56.2% | 119,399 | -3.8% | 0.00% | -100.0% |
Q1 2018 | $1,367,000 | +16.4% | 124,115 | -2.2% | 0.00% | – |
Q4 2017 | $1,174,000 | +0.9% | 126,954 | -2.0% | 0.00% | -100.0% |
Q3 2017 | $1,163,000 | +27.7% | 129,560 | 0.0% | 0.00% | – |
Q2 2017 | $911,000 | +611.7% | 129,560 | +787.4% | 0.00% | – |
Q1 2017 | $128,000 | +8.5% | 14,600 | 0.0% | 0.00% | – |
Q4 2016 | $118,000 | – | 14,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |